Hence, the findings of their study add a new dimension to the current understanding of the molecular bases of a-TCT neuroprotection in 2 ways: by identifying MRP1 as a-TCT-sensitive target and by unveiling the general prospect that oral a-TCT may regulate microRNA expression in stroke-affected brain tissue. This evidence concerns the gene ABCC1 and Stroke.